Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02613117 · ClinicalTrials.gov registry record · NA
Research on Oral Tolerability and Product Application/Response of Two Oxalate Products for Dental Patients With Risk of Dentinal Hypersensitivity
A NA study, sponsored by Procter and Gamble.
- Completed
- Registry status
- NA
- Development phase
- 104
- Enrollment target
NCT02613117 is a NA study that has completed, run by Procter and Gamble. The registered enrollment target is 104 participants.
The verdict
NCT02613117, a NA study, has completed, sponsored by Procter and Gamble.
- COMPLETED
- Registry status
- NA
- Development phase
- 104 participants
- Enrollment target
Study Summary
This study will assess the oral tolerability and immediate post-treatment safety of topical application for two marketed oxalate products as initial care in dental patients to treat or prevent tooth sensitivity pain that may be attributed to dentinal hypersensitivity.
Interventions
- DRUG Stannous fluoride paste
- DEVICE Potassium Oxalate Gel
- DEVICE Potassium Oxalate Liquid
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 104 participants |
| Start Date | 2015-11 |
| Est. Completion | 2016-06 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT02613117
The ClinicalTrials.gov registry entry for NCT02613117 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 104 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Procter and Gamble, which has 70 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 3 interventions - of which Stannous fluoride paste is the first listed.
NCT02613117 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT02613117 about?
NCT02613117 is a clinical study titled "Research on Oral Tolerability and Product Application/Response of Two Oxalate Products for Dental Patients With Risk of Dentinal Hypersensitivity". This study will assess the oral tolerability and immediate post-treatment safety of topical application for two marketed oxalate products as initial care in dental patients to treat or prevent tooth sensitivity pain that may be attributed to dentinal hypersensitivity.
What is the current status of trial NCT02613117?
This trial is currently completed. It is a NA study. The enrollment target is 104 participants. The study started on 2015-11. Estimated completion is 2016-06.
What interventions are being tested in trial NCT02613117?
The interventions under investigation include: Stannous fluoride paste (DRUG), Potassium Oxalate Gel (DEVICE), Potassium Oxalate Liquid (DEVICE).
Who is sponsoring clinical trial NCT02613117?
This trial is sponsored by Procter and Gamble, which has 70 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.